Innoviva
(NASDAQ) INVA
Innoviva Financials at a Glance
Market Cap
$1.61B
Revenue (TTM)
$414.76M
Net Income (TTM)
$271.17M
EPS (TTM)
$3.06
P/E Ratio
7.10
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$21.93
Volume
25,564
Open
$22.02
Price
$21.93
Volume
25,564
Open
$22.02
Previous Close
$21.93
Daily Range
$21.67 - $22.17
52-Week Range
$16.52 - $25.14
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$21.93
Volume
25,564
Open
$22.02
Previous Close
$21.93
Daily Range
$21.67 - $22.17
52-Week Range
$16.52 - $25.14
INVA News
INVA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Innoviva
Industry
Pharmaceuticals
Sector
Health CareEmployees
159
CEO
Pavel Raifeld, CFA, MBA
Website
www.inva.comHeadquarters
Burlingame, CA 94010, US
INVA Financials
Key Financial Metrics (TTM)
Gross Margin
79%
Operating Margin
-4%
Net Income Margin
65%
Return on Equity
29%
Return on Capital
-1%
Return on Assets
17%
Earnings Yield
14.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.61B
Shares Outstanding
74.07M
Volume
25.56K
Short Interest
0.00%
Avg. Volume
748.42K
Financials (TTM)
Gross Profit
$307.52M
Operating Income
$163.75M
EBITDA
$383.79M
Operating Cash Flow
$196.93M
Capital Expenditure
$1.13M
Free Cash Flow
$195.80M
Cash & ST Invst.
$550.94M
Total Debt
$269.02M
Innoviva Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$118.05M
+28.6%
Gross Profit
$75.61M
-10.7%
Gross Margin
64.05%
N/A
Market Cap
$1.61B
N/A
Market Cap/Employee
$12.66M
N/A
Employees
127
N/A
Net Income
$164.15M
+707.4%
EBITDA
$208.47M
+479.8%
Quarterly Fundamentals
Net Cash
$281.92M
+830.4%
Accounts Receivable
$34.97M
-59.5%
Inventory
$39.17M
+16.2%
Long Term Debt
$268.60M
+4.3%
Short Term Debt
$418.00K
-99.8%
Return on Assets
16.58%
N/A
Return on Invested Capital
-1.05%
N/A
Free Cash Flow
$53.38M
-3.4%
Operating Cash Flow
$54.51M
-8.0%